Chemed Corp. Stock
€468.00
Your prediction
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Chemed
sharewise wants to provide you with the best news and tools for Chemed, so we directly link to the best financial data sources.
Financials
News
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Stockholders of Chemed Corporation (NYSE: CHE) today elected a slate of nine directors at the Company’s 2025 annual stockholders’ meeting.
Stockholders ratified the continuation of
Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the
Chemed Reports First-Quarter 2025 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the
Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, at approximately 9:20 a.m
Chemed Reports Fourth-Quarter 2024 Results
Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest
Chemed Corporation Declares Quarterly Dividend of 50 Cents
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 50-cents per share on the Company’s capital stock, payable on March 14, 2025, to
Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27
Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2024, on Wednesday, February 26, 2025, following the close of trading
Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 43rd Annual JPMorgan Healthcare Conference on Tuesday, January 14, 2024, at approximately 10:30 a.m. PST at